Scientific Industries (SCND) stock price, revenue, and financials

Scientific Industries market cap is $12.6 m, and annual revenue was $10.20 m in FY 2019

$12.6 M

SCND Mkt cap, 26-Jun-2020

$2.4 M

Scientific Industries Revenue Q3, 2020
Scientific Industries Gross profit (Q3, 2020)1.1 M
Scientific Industries Gross profit margin (Q3, 2020), %46.4%
Scientific Industries Net income (Q3, 2020)-314.6 K
Scientific Industries EBIT (Q3, 2020)-334.9 K
Scientific Industries Cash, 31-Mar-2020739.4 K
Scientific Industries EV12.8 M

Scientific Industries Revenue

Scientific Industries revenue was $10.20 m in FY, 2019

Embed Graph

Scientific Industries Income Statement

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

1.5m1.2m1.5m1.9m1.6m1.4m1.7m1.8m1.7m1.7m1.7m1.4m2.0m1.7m1.6m2.7m1.9m1.3m1.9m2.1m2.0m2.2m3.1m2.0m2.3m2.4m

Cost of goods sold

937.0k707.2k920.5k1.0m810.7k841.9k929.7k1.1m1.2m1.1m961.9k849.4k1.2m993.1k889.5k1.9m1.1m829.1k1.1m1.3m1.1m1.2m2.0m1.0m1.2m1.3m

Gross profit

604.0k490.4k599.0k830.3k815.4k594.2k818.1k697.4k500.2k609.4k767.3k595.1k837.7k681.2k669.6k794.9k856.1k451.7k765.7k767.8k945.7k975.7k1.1m980.4k1.1m1.1m

Gross profit Margin, %

39%41%39%44%50%41%47%39%30%36%44%41%41%41%43%30%45%35%40%37%46%45%35%49%48%46%

Sales and marketing expense

189.0k160.1k170.8k191.1k188.6k197.0k207.9k198.0k295.3k229.4k202.2k167.0k227.2k196.2k216.8k224.2k223.9k201.0k214.6k263.8k236.1k248.2k282.1k309.1k330.5k433.8k

R&D expense

46.9k78.7k125.0k135.1k100.8k97.2k90.8k113.8k107.1k116.1k94.5k85.4k84.1k93.4k115.4k105.0k114.1k129.1k132.9k117.7k117.4k109.4k120.9k236.6k260.0k298.9k

General and administrative expense

290.9k335.1k318.9k309.6k320.8k303.0k342.9k461.8k326.5k446.4k433.9k408.2k395.7k426.7k412.4k409.2k435.1k428.4k407.9k470.2k416.5k462.1k492.4k510.2k510.1k524.8k

Operating expense total

526.8k573.9k614.7k635.8k610.2k597.2k641.6k773.6k728.9k791.9k730.6k660.6k707.0k716.3k744.6k738.4k773.1k758.5k755.4k851.7k770.0k819.7k895.4k1.1m1.1m1.4m

EBIT

77.2k(83.5k)(15.7k)194.5k205.2k(3.0k)176.5k(76.2k)(228.7k)(182.5k)36.7k(65.5k)130.7k(35.1k)(75.0k)56.5k83.0k(306.8k)10.3k(83.9k)175.7k156.0k185.7k(75.5k)(9.1k)(334.9k)

EBIT margin, %

5%(7%)(1%)10%13%0%10%(4%)(14%)(11%)2%(5%)6%(2%)(5%)2%4%(24%)1%(4%)9%7%6%(4%)0%(14%)

Interest expense

1.3k1.1k13.2k200.08.3k100.0300.06.1k500.0400.02.5k600.0

Interest income

6.8k5.0k4.3k3.1k5.7k3.1k5.4k1.0k800.07.4k1.1k400.05.0k300.0200.08.8k1.1k400.05.2k9.2k300.0

Pre tax profit

84.0k(78.5k)(11.4k)194.7k210.4k3.0k183.1k(79.8k)(222.9k)(182.4k)31.6k(77.9k)123.1k(48.3k)(69.6k)64.8k82.9k(306.5k)16.4k(83.9k)177.5k148.8k193.5k(75.7k)3.0k(376.5k)

Income tax expense

24.6k(23.2k)(3.2k)56.3k60.3k900.048.0k(20.1k)(61.6k)(44.4k)12.6k(17.8k)28.7k(11.4k)(20.8k)19.5k17.3k(73.9k)97.4k(46.2k)35.5k30.4k99.9k(19.5k)(600.0)(61.9k)

Net Income

59.4k(55.3k)(8.2k)138.4k150.1k2.1k135.1k(59.7k)(161.3k)(138.0k)19.0k(60.1k)94.4k(36.9k)(48.8k)45.3k65.6k(232.6k)(81.0k)(37.7k)142.0k118.4k93.6k(56.2k)3.6k(314.6k)

Scientific Industries Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

769.3k927.3k493.7k482.0k1.2m1.0m1.1m1.6m

Accounts Receivable

623.5k815.9k756.7k1.1m1.4m1.7m2.0m

Prepaid Expenses

167.8k59.0k123.1k68.6k80.3k33.5k91.2k

Inventories

1.6m1.7m2.3m2.2m2.4m2.0m2.3m2.6m

Current Assets

4.0m4.5m4.2m4.5m5.4m4.9m5.4m6.6m

PP&E

180.5k156.5k252.1k235.2k251.1k199.3k199.5k318.8k

Goodwill

589.9k589.9k705.3k705.3k705.3k705.3k705.3k705.3k

Total Assets

5.8m6.2m7.1m7.1m7.5m6.8m7.3m8.3m

Accounts Payable

114.8k156.8k373.7k227.6k342.4k139.2k428.0k569.0k

Short-term debt

781.6k892.9k

Current Liabilities

545.6k677.7k1.0m1.1m1.3m812.6k1.3m1.6m

Long-term debt

105.0k26.7k5.8k

Total Debt

886.6k919.6k26.7k400.0k6.7k5.8k

Total Liabilities

739.0k756.0k1.4m1.4m1.6m999.7k1.6m1.9m

Common Stock

67.8k67.9k74.4k75.4k75.7k75.7k75.7k

Additional Paid-in Capital

2.0m2.0m2.4m2.5m2.5m2.5m2.5m2.6m

Retained Earnings

3.1m3.4m3.2m3.2m3.4m3.3m3.1m3.7m

Total Equity

5.0m5.4m5.7m5.8m5.9m5.8m5.7m6.3m

Debt to Equity Ratio

0 x0.1 x0 x0 x

Debt to Assets Ratio

0 x0.1 x0 x0 x

Financial Leverage

1.1 x1.1 x1.3 x1.2 x1.3 x1.2 x1.3 x1.3 x

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

783.1k763.5k552.2k670.4k946.4k732.7k1.1m343.0k388.1k244.0k354.3k530.2k666.9k1.1m966.0k897.1k1.2m942.9k700.7k678.6k1.5m1.4m1.4m1.3m1.0m739.4k

Accounts Receivable

852.6k660.1k569.0k942.8k731.7k815.8k926.8k1.1m795.3k731.0k829.6k737.4k870.1k717.1k1.2m1.7m1.3m972.1k1.5m1.4m1.2m1.2m2.0m1.9m1.8m2.2m

Prepaid Expenses

148.9k177.7k156.7k86.2k63.6k105.9k84.3k125.9k184.8k160.5k111.2k145.3k55.6k54.8k211.3k122.5k73.1k170.8k146.6k92.3k67.0k101.4k65.8k93.5k62.5k80.4k

Inventories

1.6m2.0m2.1m1.8m2.2m1.8m1.9m2.2m2.3m2.4m2.6m2.3m3.3m3.7m2.6m2.1m2.2m2.3m2.4m2.7m2.3m2.7m2.7m2.7m3.0m3.0m

Current Assets

4.2m4.3m4.2m4.3m4.8m4.4m4.7m4.4m4.1m4.0m4.3m4.5m5.5m6.2m5.3m5.2m5.3m4.7m5.0m5.2m5.5m6.0m6.8m6.3m6.3m6.4m

PP&E

211.2k199.0k187.1k174.0k161.6k148.9k148.8k272.4k249.8k261.1k244.5k222.8k206.5k222.3k233.2k220.2k212.9k214.8k235.6k223.1k185.6k177.9k281.2k314.4k309.4k290.5k

Goodwill

447.9k589.9k589.9k589.9k589.9k589.9k589.9k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k705.3k

Total Assets

5.0m6.2m6.0m6.1m6.5m6.0m6.3m7.4m6.9m6.8m7.0m7.0m8.0m8.6m7.4m7.2m7.2m6.7m7.0m7.4m7.3m7.6m8.5m8.9m8.9m8.9m

Accounts Payable

106.8k241.0k151.6k142.3k139.6k161.8k151.1k234.7k342.1k422.4k325.1k201.1k372.1k422.3k320.4k300.2k343.1k376.9k379.4k394.4k362.6k570.7k451.4k457.2k474.7k451.9k

Dividends Payable

107.4k44.7k74.7k

Short-term debt

838.9k866.8k50.0k80.0k200.0k250.0k100.0k200.0k470.0k970.0k250.0k50.0k64.1k

Current Liabilities

432.7k963.6k843.1k816.6k1.1m700.1k810.6k1.2m1.1m1.1m1.3m1.1m2.1m2.7m1.4m1.3m1.0m937.3k1.2m1.4m1.2m1.4m1.8m1.5m1.3m1.7m

Long-term debt

143.2k124.2k66.1k46.5k6.7k10.8k9.2k7.5k4.0k42.3k40.6k738.0k855.4k869.2k

Total Debt

143.2k124.2k905.0k913.3k6.7k50.0k80.0k6.9k250.0k100.0k200.0k400.0k400.0k13.0k6.5k6.6k6.8k6.8k6.9k8.4k5.0k1.4k738.0k855.4k933.3k

Total Liabilities

1.2m1.1m971.1k1.2m758.4k862.2k1.6m1.4m1.4m1.6m1.3m2.2m2.8m1.6m1.4m1.2m1.1m1.4m1.9m1.5m1.7m2.5m2.6m2.5m2.9m

Common Stock

60.8k67.8k67.8k67.9k67.9k67.9k68.1k74.4k74.9k74.9k74.9k75.4k75.4k75.4k75.4k75.4k75.7k75.7k75.7k75.7k75.7k75.7k75.7k75.8k76.1k76.1k

Additional Paid-in Capital

1.6m2.0m2.0m2.0m2.0m2.0m2.0m2.4m2.4m2.4m2.5m2.5m2.5m2.5m2.5m2.5m2.5m2.5m2.5m2.5m2.6m2.6m2.6m2.6m2.6m2.6m

Retained Earnings

3.1m3.0m3.0m3.1m3.2m3.3m3.4m3.4m3.1m2.9m3.0m3.2m3.3m3.2m3.4m3.4m3.4m3.1m3.0m2.9m3.2m3.3m3.4m3.7m3.7m3.4m

Total Equity

4.6m5.0m5.0m5.1m5.2m5.3m5.4m5.8m5.5m5.4m5.4m5.7m5.8m5.8m5.9m5.9m6.0m5.6m5.5m5.5m5.8m5.9m6.0m6.3m6.3m6.0m

Debt to Equity Ratio

0 x0 x0.1 x0.1 x0 x0 x0 x0 x0 x0 x0 x0 x0 x

Debt to Assets Ratio

0 x0 x0.1 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x

Financial Leverage

1.1 x1.2 x1.2 x1.2 x1.2 x1.1 x1.2 x1.3 x1.3 x1.3 x1.3 x1.2 x1.4 x1.5 x1.3 x1.2 x1.2 x1.2 x1.3 x1.3 x1.3 x1.3 x1.4 x1.4 x1.4 x1.5 x

Scientific Industries Cash Flow

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

59.4k4.0k(4.2k)76.2k226.3k2.1k137.2k77.5k(161.3k)(299.3k)(280.3k)(60.1k)34.3k(2.6k)(48.8k)(3.4k)62.2k(232.6k)(313.6k)(351.5k)142.0k260.5k354.1k(56.2k)(52.6k)(367.2k)

Depreciation and Amortization

47.1k99.3k141.6k89.0k132.4k44.2k88.5k154.0k110.1k220.1k327.2k105.2k210.8k319.1k95.7k189.5k276.5k77.1k154.1k230.1k75.9k151.9k218.2k41.0k82.4k123.3k

Accounts Receivable

232.6k(40.1k)51.0k(319.3k)(108.2k)100.0(110.9k)(319.4k)(38.5k)25.7k(72.9k)344.3k211.6k364.6k80.2k(436.1k)(95.8k)452.3k(50.9k)254.1k227.6k(556.3k)106.4k161.7k(210.0k)

Inventories

(47.2k)(315.6k)(492.6k)(221.0k)(631.5k)(77.8k)(165.6k)(399.7k)26.3k(106.9k)(312.1k)(130.1k)(1.0m)(1.5m)(189.0k)287.1k206.2k(366.0k)(431.4k)(740.4k)(33.1k)(456.0k)(403.4k)(120.8k)998.1k(452.5k)

Accounts Payable

(21.3k)112.9k23.5k27.5k24.8k5.0k(5.7k)77.9k(31.5k)48.7k(48.6k)(26.5k)144.5k194.7k(22.0k)(42.2k)700.0237.7k240.2k255.2k(65.4k)142.7k23.4k(111.8k)(94.3k)(117.1k)

Cash From Operating Activities

(65.6k)187.2k80.7k(1.2k)329.2k(159.1k)46.8k(179.9k)(259.7k)(407.8k)(194.9k)(44.4k)(167.4k)(214.9k)(151.7k)(450.3k)204.8k103.6k(133.7k)(150.2k)460.7k397.3k484.7k(324.1k)(514.1k)(803.8k)

Purchases of PP&E

(54.9k)(61.9k)(66.1k)(25.2k)(28.1k)(8.5k)(24.6k)(47.1k)(19.7k)(52.9k)(56.5k)(6.5k)(8.4k)(45.1k)(4.7k)(18.2k)(31.5k)(68.1k)(70.5k)(900.0)(7.9k)(129.6k)(17.0k)(34.1k)(38.1k)

Cash From Investing Activities

(59.1k)(329.0k)(339.3k)(20.0k)(29.5k)(16.1k)224.5k(324.1k)54.2k14.9k62.3k(6.5k)(16.8k)(55.2k)(8.4k)(27.0k)(38.6k)(41.5k)(84.6k)(88.6k)(4.9k)(14.3k)(153.8k)(25.7k)(51.4k)(66.3k)

Short-term Borrowings

(12.2k)(60.0k)(37.6k)(56.6k)(19.4k)(38.9k)(58.5k)(20.0k)(26.7k)123.3k(1.5k)(3.2k)(254.8k)(1.6k)(3.4k)(5.0k)(1.6k)(3.3k)(5.1k)

Dividends Paid

(59.9k)(59.9k)40.1k40.1k(107.4k)107.4k(44.5k)74.7k74.7k

Cash From Financing Activities

(2.5k)(97.0k)(77.7k)(122.6k)(89.6k)(80.3k)99.9k143.2k(6.8k)99.1k369.1k869.1k(118.9k)129.4k(199.9k)(144.3k)(106.1k)(107.7k)(1.6k)(78.0k)(29.8k)7.0k7.0k7.0k

Net Change in Cash

(124.7k)(144.3k)(355.6k)(98.9k)177.1k(194.6k)181.7k(584.3k)(105.6k)(249.7k)(139.4k)48.2k184.9k599.0k(279.0k)(347.9k)(33.7k)(82.2k)(324.4k)(346.5k)454.2k305.0k301.1k(342.8k)(558.5k)(863.1k)

Interest Paid

2.7k3.8k800.01.8k2.4k1.2k2.7k4.3k4.4k4.4k27.2k200.01.1k22.0k100.0600.01.1k400.0800.01.4k

Income Taxes Paid

1.5k3.3k3.3k21.2k74.8k100.0k100.0k152.1k3.5k3.5k3.5k18.5k18.5k35.5k186.0k186.0k213.5k15.0k16.0k16.0k500.039.7k59.2k40.9k37.9k40.9k

Scientific Industries Ratios

USDQ1, 2012

Financial Leverage

1.1 x